loading

Acadia Pharmaceuticals Inc Aktie (ACAD) Neueste Nachrichten

pulisher
04:24 AM

What analysts say about ACADIA Pharmaceuticals Inc. stockPowerful profit generation - Autocar Professional

04:24 AM
pulisher
Jul 22, 2025

What drives ACADIA Pharmaceuticals Inc. stock priceSuperior capital gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is ACADIA Pharmaceuticals Inc. a good long term investmentTremendous return rates - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

ACADIA Pharmaceuticals Inc. Stock Analysis and ForecastStrong return on assets - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 19, 2025

BofA Securities Lifts ACADIA Pharmaceuticals Inc. (ACAD)’s Price Target To $23, Maintains Neutral Rating - MSN

Jul 19, 2025
pulisher
Jul 17, 2025

Bank of America Securities Sticks to Their Hold Rating for ACADIA Pharmaceuticals (ACAD) - The Globe and Mail

Jul 17, 2025
pulisher
Jul 15, 2025

Acadia Debuts New Team, Pipeline With ‘Biotech Powerhouse’ Ambitions - BioSpace

Jul 15, 2025
pulisher
Jul 14, 2025

What makes ACADIA Pharmaceuticals Inc. stock price move sharplyFree Step-by-Step Investment Guide - beatles.ru

Jul 14, 2025
pulisher
Jul 10, 2025

The $12 Billion Opportunity Bolstering This Biotech Stock - Investor's Business Daily

Jul 10, 2025
pulisher
Jul 07, 2025

ACADIA Pharmaceuticals’ SWOT analysis: stock poised for growth amid pipeline expansion - Investing.com Australia

Jul 07, 2025
pulisher
Jul 03, 2025

Acadia Pharmaceuticals Rides High On Patent Wins And Strong Pipeline - Finimize

Jul 03, 2025
pulisher
Jul 03, 2025

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Jul 03, 2025
pulisher
Jul 02, 2025

Acadia CEO sets sights on ‘much more assertive’ deals to invigorate pipeline - BioPharma Dive

Jul 02, 2025
pulisher
Jun 29, 2025

ACADIA Pharmaceuticals (NASDAQ:ACAD) Earns "Buy" Rating from Needham & Company LLC - MarketBeat

Jun 29, 2025
pulisher
Jun 27, 2025

Acadia Pharmaceuticals' Stocks Undervalue Future Blockbuster Potential - Finimize

Jun 27, 2025
pulisher
Jun 26, 2025

ACAD: ACADIA Pharmaceuticals Receives Buy Rating from Needham | ACAD Stock News - GuruFocus

Jun 26, 2025
pulisher
Jun 26, 2025

Acadia Pharmaceuticals Stock Price Undervalues Potential Market Opportunity of Nuplazid, Daybue, RBC Says - MarketScreener

Jun 26, 2025
pulisher
Jun 25, 2025

Acadia plans seven late-stage trials, five readouts through 2027 - Investing.com

Jun 25, 2025
pulisher
Jun 24, 2025

Acadia Pharmaceuticals price target raised to $38 from $26 at RBC Capital - Yahoo Finance

Jun 24, 2025
pulisher
Jun 23, 2025

ACADIA Pharmaceuticals (ACAD) Price Target Raised by RBC Capital | ACAD Stock News - GuruFocus

Jun 23, 2025
pulisher
Jun 23, 2025

Learn to Evaluate (ACAD) using the Charts - news.stocktradersdaily.com

Jun 23, 2025
pulisher
Jun 20, 2025

Acadia Pharmaceuticals (ACAD) Conducts Inducement Awards to Attract and Retain Top Talent - MSN

Jun 20, 2025
pulisher
Jun 18, 2025

ACADIA Pharmaceuticals (NASDAQ:ACAD) shareholders have earned a 21% CAGR over the last three years - Yahoo Finance

Jun 18, 2025
pulisher
Jun 18, 2025

Bavarian Nordic sells priority review voucher to US healthcare system USD 160m - medwatch.com

Jun 18, 2025
pulisher
Jun 18, 2025

10 Biotech Stocks Screaming a Buy - Insider Monkey

Jun 18, 2025
pulisher
Jun 17, 2025

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ACAD Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Neuroscience Leader Acadia Pharmaceuticals Expands Team with 41 New Hires, Awards $4.1M in Stock Options - Stock Titan

Jun 17, 2025
pulisher
Jun 17, 2025

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule. - AInvest

Jun 17, 2025
pulisher
Jun 14, 2025

Acadia wins patent appeal for key drug composition By Investing.com - Investing.com Nigeria

Jun 14, 2025
pulisher
Jun 13, 2025

Safety scares and trial misses drag down neuro biotechs into Q2 - BioWorld MedTech

Jun 13, 2025
pulisher
Jun 12, 2025

US appeals court confirms patent validity of Acadia's Parkinson's drug - MSN

Jun 12, 2025
pulisher
Jun 12, 2025

Oral Proteins & Peptides Market worth US$24.00 billion by 2030 with 22.1% CAGR | MarketsandMarkets™METRO - METRO - NEWS CHANNEL NEBRASKA

Jun 12, 2025
pulisher
Jun 11, 2025

Acadia Pharmaceuticals (ACAD) Secures Patent Win to Maintain Nup - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

US Appeals Court Confirms Patent Validity of Acadia’s Parkinson’s Medication - Insider Monkey

Jun 11, 2025
pulisher
Jun 10, 2025

Acadia wins patent appeal for key drug composition - Investing.com Australia

Jun 10, 2025
pulisher
Jun 10, 2025

Acadia gets court approval related to Nuplazid patent - MSN

Jun 10, 2025
$22.80
price up icon 4.56%
$35.91
price down icon 0.55%
$102.84
price down icon 0.11%
$27.78
price up icon 4.63%
$113.51
price up icon 1.86%
biotechnology ONC
$295.56
price up icon 0.00%
Kapitalisierung:     |  Volumen (24h):